Full-dose sofosbuvir and daclatasvir for chronic hepatitis C infection in haemodialysis patients

Neth J Med. 2016 Jun;74(5):225-7.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antiviral Agents / administration & dosage*
  • Antiviral Agents / therapeutic use
  • Carbamates
  • Female
  • Genotype
  • Hepacivirus / genetics
  • Hepatitis C, Chronic / blood
  • Hepatitis C, Chronic / complications
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Imidazoles / therapeutic use*
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / therapy*
  • Liver Cirrhosis / complications
  • Male
  • Middle Aged
  • Pyrrolidines
  • RNA, Viral / blood
  • Renal Dialysis*
  • Ribavirin / therapeutic use*
  • Sofosbuvir / administration & dosage*
  • Sustained Virologic Response
  • Valine / analogs & derivatives
  • Viral Load

Substances

  • Antiviral Agents
  • Carbamates
  • Imidazoles
  • Pyrrolidines
  • RNA, Viral
  • Ribavirin
  • Valine
  • daclatasvir
  • Sofosbuvir